Amicus Therapeutics
$10.48
24H
Market Cap
Volume
Supply
Price Chart
About Amicus Therapeutics - FOLD
Amicus Therapeutics, Inc. is a biotechnology company that focuses on the discovery, development, and delivery of medicines for patients affected by rare metabolic diseases. Their research primarily centers on lysosomal storage disorders and the development of enzyme replacement therapies and other treatments to address the underlying causes of these conditions.
What are Amicus Therapeutics's core values and mission statement?
Amicus Therapeutics, Inc. is dedicated to delivering novel medicines for rare and orphan diseases, with a focus on improving the lives of patients. Their mission revolves around the commitment to science, innovation, and the passion to make a meaningful difference in the lives of those with rare metabolic disorders.
Who founded Amicus Therapeutics and when?
Amicus Therapeutics, Inc. was founded by John F. Crowley in 2002.
Who leads Amicus Therapeutics?
John F. Crowley serves as the Chairman and Chief Executive Officer of Amicus Therapeutics, Inc.
Where is Amicus Therapeutics located, and what is its base country?
Amicus Therapeutics, Inc. is headquartered in Cranbury, New Jersey, United States.
On which exchanges is Amicus Therapeutics traded?
Amicus Therapeutics, Inc. is traded on the NASDAQ Global Market under the ticker symbol FOLD.
Historical data
Amicus Therapeutics (FOLD) Price Live Data
The live price of Amicus Therapeutics (FOLD) is $10.48, with a trading volume of 1,187,047 in the last 24 hours. Wrapstocks updates the FOLD price in real-time. Amicus Therapeutics is up 4.28% in the last 24 hours. The company has a live market cap of $3,108,273,664.00 and a supply of 296,590,998 FOLD stocks.
Amicus Therapeutics (FOLD) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 7 hours and 16 minutes.
